|
|
Office Locations:
|
10 East 53rd Street, 31st Floor
New York, NY 10022
Phone: 212-931-0250
Fax: 212-931-0236
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Altaris Capital Partners, LLC is an investment firm focused exclusively on companies operating in the healthcare industry. Altaris is based in New York and has more than $775 million of assets under management. Altaris invests in companies that operate across the healthcare continuum, including the pharmaceuticals, medical devices, healthcare services and healthcare IT sectors. The firm targets businesses in the U.S. and Western Europe with strong management teams that are generating revenue and positive cash flow. Altaris makes control and significant minority investments that typically range in size from $15-50 million of equity. The firm's investment approach is flexible and creative, but the most common types of transactions in which Altaris participates include: Corporate carve-outs; Leveraged buyouts; and Growth equity/recapitalization investments. Altaris currently manages $6.0 billion of equity capital.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
